糖尿病腎症における細胞アポトーシスの調節経路および中医学的介入研究の進展

  • role: First author第一作者
  • Affiliation:

    Fujian Provincial People's Hospital,Fuzhou 350004,China

    The First Clinical Medical College of Fujian University of Traditional Chinese Medicine,Fuzhou 350004,China

  • Email:402559850@qq.com
  • Introduction:杨运劼,在读博士,从事中西医结合防治肾脏病基础与临床研究,E-mail:402559850@qq.com
YANG Yunjie12,  
  • Affiliation:

    Fujian Provincial People's Hospital,Fuzhou 350004,China

    The First Clinical Medical College of Fujian University of Traditional Chinese Medicine,Fuzhou 350004,China

JIANG Mingqian12,  
  • Affiliation:

    Fujian Provincial People's Hospital,Fuzhou 350004,China

QIU Chen1,  
  • Affiliation:

    Fujian Provincial People's Hospital,Fuzhou 350004,China

    The First Clinical Medical College of Fujian University of Traditional Chinese Medicine,Fuzhou 350004,China

RUAN Yaqing12,  
  • Affiliation:

    The First Clinical Medical College of Fujian University of Traditional Chinese Medicine,Fuzhou 350004,China

CHEN Senlin2,  
  • Affiliation:

    The First Clinical Medical College of Fujian University of Traditional Chinese Medicine,Fuzhou 350004,China

HUANG Wenxin2,  
  • Affiliation:

    The First Clinical Medical College of Fujian University of Traditional Chinese Medicine,Fuzhou 350004,China

ZHENG Hangbin2,  
  • Affiliation:

    The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine,Shenzhen 518033,China

WEI Yi3,  
  • Affiliation:

    Fujian Provincial People's Hospital,Fuzhou 350004,China

LI Pengfei1,  
  • Affiliation:

    Fujian Provincial People's Hospital,Fuzhou 350004,China

LIN Xueqin1,  
  • Affiliation:

    Fujian Provincial People's Hospital,Fuzhou 350004,China

WU Jing1,  
  • Affiliation:

    Fujian Provincial People's Hospital,Fuzhou 350004,China

RUAN Shiwei1,  
  • role: Corresponding author通信作者
  • Affiliation:

    Fujian Provincial People's Hospital,Fuzhou 350004,China

  • Email:510207742@qq.com
  • Introduction:王建挺,主任医师,副教授,硕士生导师,从事中西医结合防治肾脏病基础与临床研究,E-mail:510207742@qq.com; *
WANG Jianting1*,  
  • role: Corresponding author通信作者
  • Affiliation:

    Fujian Provincial People's Hospital,Fuzhou 350004,China

  • Email:748778837@qq.com
  • Introduction:丘余良,主任医师,教授,硕士生导师,从事中西医结合防治肾脏病基础与临床研究,E-mail:748778837@qq.com
QIU Yuliang1*

サマリー

糖尿病性腎症(DKD)は糖尿病によって引き起こされる慢性的な腎臓の構造および機能障害である。世界的に糖尿病の罹患率が継続的に増加する中、DKDは慢性腎疾患および末期腎不全(ESRD)の主要な原因となりつつあり、患者の生活の質および健康予後に深刻な影響を及ぼしている。研究によれば、アポトーシスはDKDの発症と進展において重要な役割を果たしており、その機序はToll様受容体4(TLR4)/核内転写因子-κB(NF-κB)/B細胞リンパ腫-2(Bcl-2)/カスパーゼ-3、タンパク質キナーゼR様小胞体キナーゼ(PERK)/真核翻訳開始因子2α(eIF2α)/活性化転写因子4(ATF4)/CCAATエンハンサー結合タンパク質ホモログ(CHOP)、ホスファチジルイノシトール3キナーゼ(PI3K)/プロテインキナーゼB(Akt)/グリコーゲン合成酵素キナーゼ-3β(GSK-3β)、ヤヌスキナーゼ2(JAK2)/シグナル伝達および転写活性化因子3(STAT3)、AMP活性化プロテインキナーゼ(AMPK)/哺乳類ラパマイシン標的タンパク質(mTOR)、サイレンシング情報調節因子1(SIRT1)/腫瘍抑制タンパク質53(p53)など多くのシグナル経路の異常活性化を含み、これがDKDの腎臓病理学的損傷を促進する。多くのエビデンスに基づく医療研究は、中国伝統医学が多標的、多成分、多経路という独特の治療的利点により、DKD治療において顕著な効果と良好な安全性を示していることを証明している。近年の研究では、中薬の有効成分がアポトーシスシグナル経路中の重要なエフェクター因子を標的制御できることが示されており、複方製剤は補気活血、解毒通絡、益腎固本、去瘀泄濁など多重の効果により、細胞内小器官の内質網およびミトコンドリアのアポトーシス経路など重要な病理段階に協調的に介入する。このような「分子標的」と「全体調節」の治療モデルは、DKDの進行遅延に新たな治療戦略を提供する。これに基づき、本稿は細胞アポトーシスの主要なシグナル経路およびその調節機構を深く分析し、近年の中薬有効成分、中薬複方、中成薬が上述の経路を介してDKDを治療する最新の研究進展と潜在的な分子機序を系統的に整理し、中医学によるDKD治療の現代科学的内涵と理論的根拠を明確にするとともに、DKD治療分野における中医学の広範な応用と深化研究を促進するための堅固な理論的かつ実践的基盤を提供することを目的とする。

キーワード

糖尿病腎症;アポトーシス;シグナル経路;ミトコンドリア;小胞体;中医学;作用機序

References

  1. 1.
    Chinese Diabetes Society.Guideline for the prevention and treatment of diabetes mellitus in China(2024 edition)[J].Chin J Diabetes Mellit,2025,17(1):16-139.
  2. 2.
    The Lancet. .Diabetes:A defining disease of the 21st century[J].Lancet,2023,401(10394):2087.
  3. 3.
    YE X,YU R,JIANG F,et al.Osteocalcin and risks of incident diabetes and diabetic kidney disease:A 4.6-year prospective cohort study[J].Diabetes Care,2022,45(4):830-836.
  4. 4.
    Diabetic Kidney Disease Group of Endocrine Committee of Chinese Association of Integrative Medicine,Chinese Medicine and Microcirculation Committee of the Chinese Society of Microcirculation.Expert consensus on the prevention and treatment of diabetic kidney disease with the integrated traditional Chinese and Western medicine(2023 edition)[J].Chin J Diabetes Mellitus,2023,15(8):690-702.
  5. 5.
    SUN Y,WANG X D,CUI Y Z,et al.Exploring academic characteristics of contemporary Chinese medicine masters in treating diabetic nephropathy based on SrTO[J].Chin J Exp Tradit Med Form,2025,doi:.
  6. 6.
    China Association of Chinese Medicine;Dongzhimen Hospital,Beijing University of Chinese Medicine;Beijing University of Chinese Medicine.Diagnosis and treatment guideline of integrated traditional Chinese and western medicine for diabetic kidney disease[J].J Beijing Univ Tradit Chin Med,2024,47(4):580-592.
  7. 7.
    YANG C,ZHANG Z,LIU J,et al.Research progress on multiple cell death pathways of podocytes in diabetic kidney disease[J].Mol Med,2023,29(1):135.
  8. 8.
    EREKAT N S.Programmed cell death in diabetic nephropathy:A review of apoptosis,autophagy,and necroptosis[J].Med Sci Monit,2022,28:e937766.
  9. 9.
    GONG Y X.Research progress of effective components of traditional Chinese medicine in intervening apoptosis of renal tubular epithelial cells in diabetic kidney disease[J].J Ethnopharmacol,2025,348:119874.
  10. 10.
    LOSSI L.The concept of intrinsic versus extrinsic apoptosis[J].Biochem J,2022,479(3):357-384.
  11. 11.
    KERR J F,WYLLIE A H,CURRIE A R.Apoptosis:A basis biological phenomenon with wide-ranging implications in tissue kinetics[J].Br J Cancer,1972,26(4):239-257.
  12. 12.
    MORRIS D L,TJANDRA N.Inducible fold-switching as a mechanism to fibrillate pro-apoptotic Bcl-2 proteins[J].Biopolymers,2021,112(10):e23424.
  13. 13.
    ELENA-REAL C A,DÍAZ-QUINTANA A,GONZÁLEZ-ARZOLA K,et al.Cytochrome c speeds up caspase cascade activation by blocking 14-3-3ε-dependent Apaf-1 inhibition[J].Cell Death Dis,2018,9(3):365.
  14. 14.
    LI H,FAN J,ZHAO Y,et al.Calcium alleviates fluoride-induced kidney damage via Fas/FasL,TNFR/TNF,DR5/TRAIL pathways in rats[J].Ecotoxicol Environ Saf,2021,226:112851.
  15. 15.
    MANDAL R,BARRÓN J C,KOSTOVA I,et al.Caspase-8:The double-edged sword[J].Biochim Biophys Acta Rev Cancer,2020,1873(2):188357.
  16. 16.
    ZHANG R,BIAN C,GAO J,et al.Endoplasmic reticulum stress in diabetic kidney disease:Adaptation and apoptosis after three UPR pathways[J].Apoptosis,2023,28(7/8):977-996.
  17. 17.
    XIE Y,E J,CAI H,et al.Reticulon-1A mediates diabetic kidney disease progression through endoplasmic reticulum-mitochondrial contacts in tubular epithelial cells[J].Kidney Int,2022,102(2):293-306.
  18. 18.
    ANSON F,THAYUMANAVAN S,HARDY J A.Exogenous introduction of initiator and executioner caspases results in different apoptotic outcomes[J].JACS Au,2021,1(8):1240-1256.
  19. 19.
    SPITZ A Z,GAVATHIOTIS E.Physiological and pharmacological modulation of Bax[J].Trends Pharmacol Sci,2022,43(3):206-220.
  20. 20.
    AUBREY B J,KELLY G L,JANIC A,et al.How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression?[J].Cell Death Differ,2018,25(1):104-113.
  21. 21.
    ZHANG K,WU D,HUANG C.Crosstalk between non-coding RNA and apoptotic signaling in diabetic nephropathy[J].Biochem Pharmacol,2024,230(Pt 3):116621.
  22. 22.
    ZHANG D,JING B,CHEN Z N,et al.Ferulic acid alleviates sciatica by inhibiting neuroinflammation and promoting nerve repair via the TLR4/NF-κB pathway[J].CNS Neurosci Ther,2023,29(4):1000-1011.
  23. 23.
    WANG Y,XIAO L,YIN Q Q,et al.SOCS3 promotes the high glucose-induced inflammatory factors expression in rat mesangial cells through TLR4/NF-κB signaling pathway[J].Curr Immunol,2024,44(4):316-322.
  24. 24.
    FENG Q,YU X,XIE J,et al.Phillygenin improves diabetic nephropathy by inhibiting inflammation and apoptosis via regulating TLR4/MyD88/NF-κB and PI3K/Akt/GSK3β signaling pathways[J].Phytomedicine,2025,136:156314.
  25. 25.
    SHI G,LIU L,CAO Y,et al.Inhibition of neutrophil extracellular trap formation ameliorates neuroinflammation and neuronal apoptosis via STING-dependent IRE1α/ASK1/JNK signaling pathway in mice with traumatic brain injury[J].J Neuroinflammation,2023,20(1):222.
  26. 26.
    NADEL G,MAIK-RACHLINE G,SEGER R.JNK cascade-induced apoptosis-a unique role in GqPCR signaling[J].Int J Mol Sci,2023,24(17):13527.
  27. 27.
    ZHAO G,ZHANG X,WANG H,et al.Beta carotene protects H9c2 cardiomyocytes from advanced glycation end product-induced endoplasmic reticulum stress,apoptosis,and autophagy via the PI3K/Akt/mTOR signaling pathway[J].Ann Transl Med,2020,8(10):647.
  28. 28.
    HU H,TIAN M,DING C,et al.The C/EBP homologous protein(CHOP)transcription factor functions in endoplasmic reticulum stress-induced apoptosis and microbial infection[J].Front Immunol,2018,9:3083.
  29. 29.
    NAKAGAWA T,ZHU H,MORISHIMA N,et al.Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta[J].Nature,2000,403(6765):98-103.
  30. 30.
    WANG Y X,XIE J X,ZHANG X P,et al.The inhibitory effect of Averrhoa carambola DMDD on high glucose-induced endoplasmic reticulum stress IRE1α pathway and inflammation in renal tubular epithelial cell HK-2[J].Chin Pharmacol Bull,2023,39(7):1270-1275.
  31. 31.
    BELALI O M,AHMED M M,MOHANY M,et al.LCZ696 protects against diabetic cardiomyopathy-induced myocardial inflammation,ER Stress,and apoptosis through inhibiting AGEs/NF-κB and PERK/CHOP signaling pathways[J].Int J Mol Sci,2022,23(3):1288.
  32. 32.
    ZHANG F,NI Z,ZHAO S,et al.Flurochloridone induced cell apoptosis via ER Stress and eIF2α-ATF4/ATF6-CHOP-Bim/Bax signaling pathways in mouse TM4 Sertoli cells[J].Int J Environ Res Public Health,2022,19(8):4564.
  33. 33.
    JU Y,SU Y,CHEN Q,et al.Protective effects of astragaloside Ⅳon endoplasmic reticulum stress-induced renal tubular epithelial cells apoptosis in type 2 diabetic nephropathy rats[J].Biomed Pharmacother,2019,109:84-92.
  34. 34.
    LIANG S,LIU H,LIU S,et al.Homocysteine induces human mesangial cell apoptosis via the involvement of autophagy and endoplasmic reticulum stress[J].RSC Adv,2019,9(54):31720-31727.
  35. 35.
    WANG H,GAO L,ZHAO C,et al.The role of PI3K/Akt signaling pathway in chronic kidney disease[J].Int Urol Nephrol,2024,56(8):2623-2633.
  36. 36.
    LIU H,WANG J,ZHANG Q,et al.Protective effect of fucoidan against MPP+-induced SH-SY5Y cells apoptosis by affecting the PI3K/Akt pathway[J].Mar Drugs,2020,18(6):333.
  37. 37.
    GUO J,JIANG X,LIAN J,et al.Evaluation of the effect of GSK-3β on liver cancer based on the PI3K/Akt pathway[J].Front Cell Dev Biol,2024,12:1431423.
  38. 38.
    GHAFFARI-NASAB A,GHIASI F,KEYHANMANESH R,et al.Bone marrow-derived c-kit positive stem cell administration protects against diabetes-induced nephropathy in a rat model by reversing PI3K/Akt/GSK-3β pathway and inhibiting cell apoptosis[J].Mol Cell Biochem,2024,479(3):603-615.
  39. 39.
    WANG T Y.Phillyrin ameliorates diabetic nephropathy through the PI3K/Akt/GSK-3β pathway in streptozotocin-induced diabetic mice[D].Yichun:Yichun University,2021.
  40. 40.
    ASHRAFIZADEH M,RAFIEI H,MOHAMMADINEJAD R,et al.Potential therapeutic effects of curcumin mediated by JAK/STAT signaling pathway:A review[J].Phytother Res,2020,34(8):1745-1760.
  41. 41.
    YU J,WU H,LIU Z Y,et al.Advanced glycation end products induce the apoptosis of and inflammation in mouse podocytes through CXCL9-mediated JAK2/STAT3 pathway activation[J].Int J Mol Med,2017,40(4):1185-1193.
  42. 42.
    WANG L,LU F J,LI W.Effects of lncRNA ARAP1-AS2 on diabetic nephropathy in mice via JAK2/STAT3 signaling pathway[J].Chin J Gerontol,2023,43(11):2795-2799.
  43. 43.
    LV N,LI C,LIU X,et al.MiR-34b alleviates high glucose-induced inflammation and apoptosis in human HK-2 cells via IL-6R/JAK2/STAT3 signaling pathway[J].Med Sci Monit,2019,25:8142-8151.
  44. 44.
    EL-AZAB M F,AL-KARMALAWY A A,ANTAR S A,et al.A novel role of Nano selenium and sildenafil on streptozotocin-induced diabetic nephropathy in rats by modulation of inflammatory,oxidative,and apoptotic pathways[J].Life Sci,2022,303:120691.
  45. 45.
    JUSZCZAK F,CARON N,MATHEW A V,et al.Critical role for AMPK in metabolic disease-induced chronic kidney disease[J].Int J Mol Sci,2020,21(21):7994.
  46. 46.
    SELIM S M,EL-FAYOUMI H M,EL-SAYED N M,et al.Alogliptin attenuates STZ-induced diabetic nephropathy in rats through the modulation of autophagy,apoptosis,and inflammation pathways:Targeting NF-κB and AMPK/mTOR pathway[J].Life Sci,2025,361:123307.
  47. 47.
    YE Y Y,CHEN Y,YANG J,et al.Dapagliflozin restores autophagy and attenuates apoptosis via the AMPK/mTOR pathway in diabetic nephropathy rats and high glucose-induced HK-2 cells[J].Int Urol Nephrol,2025,57(1):249-261.
  48. 48.
    SANAJOU D,GHORBANI HAGHJO A,ARGANI H,et al.AGE-RAGE axis blockade in diabetic nephropathy: Current status and future directions[J].Eur J Pharmacol,2018,833:158-164.
  49. 49.
    OTT C,JACOBS K,HAUCKE E,et al.Role of advanced glycation end products in cellular signaling[J].Redox Biol,2014,2:411-429.
  50. 50.
    MALLIPATTU S K,URIBARRI J.Advanced glycation end product accumulation:A new enemy to target in chronic kidney disease?[J].Curr Opin Nephrol Hypertens,2014,23(6):547-554.
  51. 51.
    CUI F,GAO Y,ZHAO W,et al.Effect of Tongxinluo on podocyte apoptosis via inhibition of oxidative stress and p38 pathway in diabetic rats[J].Evid Based Complement Alternat Med,2016,2016:5957423.
  52. 52.
    YANG P Y,LI P C,FENG B.Protective effects of gliclazide on high glucose and AGEs-induced damage of glomerular mesangial cells and renal tubular epithelial cells via inhibiting RAGE-p22phox-NF-κB pathway[J].Eur Rev Med Pharmacol Sci,2019,23(20):9099-9107.
  53. 53.
    CHEN Y,CHEN J,JIANG M,et al.Loganin and catalpol exert cooperative ameliorating effects on podocyte apoptosis upon diabetic nephropathy by targeting AGEs-RAGE signaling[J].Life Sci,2020,252:117653.
  54. 54.
    WAHAB N A A,GIRIBABU N,KILARI E K,et al.Abietic acid ameliorates nephropathy progression via mitigating renal oxidative stress,inflammation,fibrosis and apoptosis in high fat diet and low dose streptozotocin-induced diabetic rats[J].Phytomedicine,2022,107:154464.
  55. 55.
    JI J,TAO P,WANG Q,et al.SIRT1:Mechanism and protective effect in diabetic nephropathy[J].Endocr Metab Immune Disord Drug Targets,2021,21(5):835-842.
  56. 56.
    ONG A L C,RAMASAMY T S.Role of Sirtuin1-p53 regulatory axis in aging,cancer and cellular reprogramming[J].Ageing Res Rev,2018,43:64-80.
  57. 57.
    HAN X,WANG J,LI R,et al.Placental mesenchymal stem cells alleviate podocyte injury in diabetic kidney disease by modulating mitophagy via the SIRT1-PGC-1alpha-TFAM pathway[J].Int J Mol Sci,2023,24(5):4696.
  58. 58.
    WANG Y,ZHENG Z J,JIA Y J,et al.Role of p53/miR-155-5p/sirt1 loop in renal tubular injury of diabetic kidney disease[J].J Transl Med,2018,16(1):146.
  59. 59.
    WANG X L,WU L Y,ZHAO L,et al.SIRT1 activator ameliorates the renal tubular injury induced by hyperglycemia in vivo and in vitro via inhibiting apoptosis[J].Biomed Pharmacother,2016,83:41-50.
  60. 60.
    ZHANG S Q,ZHANG Y W,SHUAI Y,et al.Effects of Danggui Buxue decoction on expressions of ATF6,CHOP and Caspase-3 in renal tissue of diabetic nephropathy rats[J].Shanghai J Tradit Chin Med,2018,52(4):91-95.
  61. 61.
    ZHANG R D,SHI M.Occurrence and development of diabetic nephropathy caused by CD63 by inhibiting Wnt-β-catenin signaling pathway[J].Eur Rev Med Pharmacol Sci,2020,24(1):284-294.
  62. 62.
    GAO F,YAO M,SHI Y,et al.Notch pathway is involved in high glucose-induced apoptosis in podocytes via Bcl-2 and p53 pathways[J].J Cell Biochem,2013,114(5):1029-1038.
  63. 63.
    WU G J,ZHAO H B,ZHANG X W.Death-associated protein kinase 1 correlates with podocyte apoptosis and renal damage and can be mediated by miR-361[J].Histol Histopathol,2021,36(11):1155-1167.
  64. 64.
    XIAO L,LUO D,PI P,et al.Up-regulation of miR-135b expression induced by oxidative stress promotes the apoptosis of renal tubular epithelial cells under high glucose condition[J].Clin Exp Pharmacol Physiol,2020,47(8):1410-1419.
  65. 65.
    NIE Y,FU C,ZHANG H,et al.Celastrol slows the progression of early diabetic nephropathy in rats via the PI3K/Akt pathway[J].BMC Complement Med Ther,2020,20(1):321.
  66. 66.
    WANG Y,LIU Y,CHEN S,et al.The protective mechanism of Dehydromiltirone in diabetic kidney disease is revealed through network pharmacology and experimental validation[J].Front Pharmacol,2023,14:1201296.
  67. 67.
    SU W Y,LI Y,CHEN X,et al.Ginsenoside Rh1 improves type 2 diabetic nephropathy through AMPK/PI3K/Akt-mediated inflammation and apoptosis signaling pathway[J].Am J Chin Med,2021,49(5):1215-1233.
  68. 68.
    WANG X,JIANG L,LIU X Q,et al.Paeoniflorin binds to VEGFR2 to restore autophagy and inhibit apoptosis for podocyte protection in diabetic kidney disease through PI3K-Akt signaling pathway[J].Phytomedicine,2022,106:154400.
  69. 69.
    GAO Y.Efficacy and mechanism of inhibiting endoplasmic reticulum stress to reduce podocyte apoptosis in diabetic kidney disease by Triptolide[D].Jinan:Shandong University of Traditional Chinese Medicine,2024.
  70. 70.
    DU Y,CHEN Z,WEI L T,et al.Mechanism of tenuigenin on high glucose-induced renal tubular epithelial cell damage through TLR4/NF-κB signaling pathway[J].Chin J Gerontol,2024,44(9):2152-2156.
  71. 71.
    ZHONG Y,LUO R,LIU Q,et al.Jujuboside A ameliorates high fat diet and streptozotocin induced diabetic nephropathy via suppressing oxidative stress,apoptosis,and enhancing autophagy[J].Food Chem Toxicol,2022,159:112697.
  72. 72.
    SHEN B X,WANG F C,ZHOU Y,et al.Ginsenoside Rh2 inhibits renal fibrosis and renal cell apoptosis in rats with diabetic nephropathy by downregulating discoid domain receptor 1[J].J South Med Univ,2021,41(7):1107-1113.
  73. 73.
    CHEN Y,PENG Y,LI P,et al.Ginsenoside Rg3 induces mesangial cells proliferation and attenuates apoptosis by miR-216a-5p/MAPK pathway in diabetic kidney disease[J].Aging(Albany NY),2024,16(11):9933-9943.
  74. 74.
    LIU X Q,JIANG L,LI Y Y,et al.Wogonin protects glomerular podocytes by targeting Bcl-2-mediated autophagy and apoptosis in diabetic kidney disease[J].Acta Pharmacol Sin,2022,43(1):96-110.
  75. 75.
    WAN B Y,CAO D W,WAN Y G,et al.Effects and mechanisms of total flavones of Abelmoschus manihot in attenuating diabetic tubulopathy by targeting endoplasmic reticulum stress-induced cell apoptosis[J].China J Chin Mater Med,2023,48(10):2657-2666.
  76. 76.
    LIU F,FENG Q,YANG M,et al.Quercetin prevented diabetic nephropathy by inhibiting renal tubular epithelial cell apoptosis via the PI3K/Akt pathway[J].Phytother Res,2024,38(7):3594-3606.
  77. 77.
    LIU Y,LI Y,XU L,et al.Quercetin attenuates podocyte apoptosis of diabetic nephropathy through targeting EGFR signaling[J].Front Pharmacol,2022,12:792777.
  78. 78.
    LI J,LING Y,YIN S,et al.Baicalin serves a protective role in diabetic nephropathy through preventing high glucose-induced podocyte apoptosis[J].Exp Ther Med,2020,20(1):367-374.
  79. 79.
    WU H,YANG L,TANG L Q,et al.Berberine inhibits JAK2/STAT3 signaling pathway to alleviate high glucose induced podocyte EMT and apoptosis[J].Acta Univ Med Anhui,2022,57(8):1189-1194.
  80. 80.
    WANG Y F.The role of endoplasmic reticulum stress in diabetic nephropathy and the intervention mechanism of Berberine[D].Bengbu:Bengbu Medical University,2023.
  81. 81.
    XU J,LIU L,GAN L,et al.Berberine acts on C/EBPβ/lncRNA gas5/miR-18a-5p loop to decrease the mitochondrial ROS generation in HK-2 cells[J].Front Endocrinol(Lausanne),2021,12:675834.
  82. 82.
    SU L,CAO P,WANG H.Tetrandrine mediates renal function and redox homeostasis in a streptozotocin-induced diabetic nephropathy rat model through Nrf2/HO-1 reactivation[J].Ann Transl Med,2020,8(16):990.
  83. 83.
    XU Y M,LI X Q,XU C,et al.Astragalus polysaccharide regulates SIRT1 to inhibit oxidative stress and apoptosis of renal foot cells induced by high glucose[J].Chin J Integr Tradit West Med,2024,44(10):1221-1227.
  84. 84.
    XU Y,XU C,HUANG J,et al.Astragalus polysaccharide attenuates diabetic nephropathy by reducing apoptosis and enhancing autophagy through activation of Sirt1/FoxO1 pathway[J].Int Urol Nephrol,2024,56(9):3067-3078.
  85. 85.
    ZHANG T,SUN W,WANG L,et al.Rosa laevigata Michx. polysaccharide ameliorates diabetic nephropathy in mice through inhibiting ferroptosis and PI3K/Akt pathway-mediated apoptosis and modulating tryptophan metabolism[J].J Diabetes Res,2023,2023:9164883.
  86. 86.
    WANG F,LI R,ZHAO L,et al.Resveratrol ameliorates renal damage by inhibiting oxidative stress-mediated apoptosis of podocytes in diabetic nephropathy[J].Eur J Pharmacol,2020,885:173387.
  87. 87.
    SUN X J,WU A N,HOU N,et al.Effects of aerobic exercise and resveratrol on the inflammation and apoptosis in kidney tissue of diabetes rats[J].Nat Prod Res Dev,2024,36(6):946-953.
  88. 88.
    ZHANG P,FANG J,ZHANG J,et al.Curcumin inhibited podocyte cell apoptosis and accelerated cell autophagy in diabetic nephropathy via regulating Beclin-1/UVRAG/Bcl-2[J].Diabetes Metab Syndr Obes,2020,13:641-652.
  89. 89.
    XIE W W,HE Z L,ZHAO X J,et al.Effects of Curcumin on the proliferation and apoptosis of NRK-52E cells in high glucose-induced impaired glucose tolerance rats[J].Chin Traditi Pat Med,2022,44(5):1617-1621.
  90. 90.
    SHEN Q,FANG J,GUO H,et al.AstragalosideⅣattenuates podocyte apoptosis through ameliorating mitochondrial dysfunction by up-regulated Nrf2-ARE/TFAM signaling in diabetic kidney disease[J].Free Radic Biol Med,2023,203:45-57.
  91. 91.
    XING L,FANG J,ZHU B,et al.Astragaloside Ⅳ protects against podocyte apoptosis by inhibiting oxidative stress via activating PPARγ-Klotho-FoxO1 axis in diabetic nephropathy[J].Life Sci,2021,269:119068.
  92. 92.
    WANG Z S,GAO W,CHEN D,et al.Influence of AstragalosideⅣon inhibiting endoplasmic reticulum stress and CHOP signaling pathways and improving tunicamycin induced mesangial cells apoptosis[J].Her Med,2022,41(2):150-154.
  93. 93.
    ZHONG Y,LIU J,SUN D,et al.Dioscin relieves diabetic nephropathy via suppressing oxidative stress and apoptosis,and improving mitochondrial quality and quantity control[J].Food Funct,2022,13(6):3660-3673.
  94. 94.
    ZHONG Y,WANG L,JIN R,et al.Diosgenin inhibits ROS generation by modulating Nox-4 and mitochondrial respiratory chain and suppresses apoptosis in diabetic nephropathy[J].Nutrients,2023,15(9):2164.
  95. 95.
    YAN M M,XU L L,LIU Y Y,et al.Effects of amygdalin on renal tubular epithelial cell injury in diabetes nephropathy rats[J].Chin J Clin Pharmacol,2024,40(7):1019-1023.
  96. 96.
    WANG T,WEN X,ZHANG Z,et al.Phillyrin ameliorates diabetic nephropathy through the PI3K/Akt/GSK-3β signalling pathway in streptozotocin-induced diabetic mice[J].Hum Exp Toxicol,2021,40(12_suppl):S487-S496.
  97. 97.
    LI C,ZHONG H,MA J,et al.Notoginsenoside R1 can inhibit the interaction between FGF1 and VEGFA to retard podocyte apoptosis[J].BMC Endocr Disord,2023,23(1):140.
  98. 98.
    HE Q,LIU F,WANG H L,et al.Protective effects of echinacoside on renal function,renal tissue and mesangial cell injury in rats with diabetic nephropathy[J].Tradit Chin Drug Res Clin Pharmacol,2020,31(9):1029-1036.
  99. 99.
    GUO C,LI Y,ZHANG R,et al.Protective effect of salidroside against diabetic kidney disease through inhibiting Bim-mediated apoptosis of proximal renal tubular cells in rats[J].Front Pharmacol,2018,9:1433.
  100. 100.
    ZHANG H,ZHAO Y X,YANG H R,et al.Effects and mechanism of safflower yellow on podocyte injury induced by high glucose[J].Chin Tradit Pat Med,2021,43(11): 3007-3013.
  101. 101.
    ZHANG W J,XU X Y.Effects of chlorogenic acid on renal inflammation and apoptosis in diabetes nephropathy rats based on TLR4/NF-κB signaling pathway[J].Mod J Integr Tradit Chin West Med,2022,31(19):2629-2635.
  102. 102.
    TIAN N,GAO Y,WANG X,et al.Emodin mitigates podocytes apoptosis induced by endoplasmic reticulum stress through the inhibition of the PERK pathway in diabetic nephropathy[J].Drug Des Devel Ther,2018,12:2195-2211.
  103. 103.
    WANG Y H,ZHANG L M,FENG Y Y.Effect of emodin on improving the inflammation,oxidative stress and apoptosis of human glomerular endothelial cells in high glucose conditions[J].Chin J ClinPharmacol,2023,39(10):1422-1426.
  104. 104.
    CHEN F,SUN Z,ZHU X,et al.Astilbin inhibits high glucose-induced autophagy and apoptosis through the PI3K/Akt pathway in human proximal tubular epithelial cells[J].Biomed Pharmacother,2018,106:1175-1181.
  105. 105.
    YANG F W,GAO F,CHEN S Z,et al.Yiqiyangyin Huoxuetongluo prescription reduces renal cell apoptosis in rats with diabetic nephropathy by inhibiting JAK2/STAT3 signaling pathway[J].Chin J Exp Tradit Med Form,2021,27(11):89-97.
  106. 106.
    WEI M Y,GAO Y Y,FANG Z Y,et al.Effect of Bushen Huoxue formula containing serum on AGE-BSA induced apoptosis of HK-2 cells and the PERK-ATF4-CHOP signaling pathway[J].Chin J Integr Tradit West Med,2023,43(7):831-838.
  107. 107.
    WANG Z M,XIANG Q,MEI S S,et al.Effect of Danggui Shaoyao powder on podocyte injury induced by high glucose through AMPK/mTOR pathway[J].Chin J Hosp Pharm,2023,43(24):2743-2748,2769.
  108. 108.
    HU T T,FAN L F,GUO Y Q,et al.Effect of Qigui Didang decoction in improving metabolic memory of diabetic nephropathy through Sirt1/p53/NF-κB p65 pathway[J].Chin J Exp Tradit Med Form,2025,31(18):20-29.
  109. 109.
    GUO J F,YANG Y F,SHI Y.Effects and mechanism of Yitangkang(益糖康)on proliferation and apoptosis of human renal tubular epithelial cells HK-2 induced by high glucose[J].Chin Arch Tradit Chin Med,2021,39(7):17-20.
  110. 110.
    WANG Y,PENG L,LU X,et al.Tangshen formula protects against podocyte apoptosis via enhancing the TFEB-mediated autophagy-lysosome pathway in diabetic nephropathy[J].J Ethnopharmacol,2024,324:117721.
  111. 111.
    CHANG J,ZHENG J,GAO X,et al.TangShenWeiNing formula prevents diabetic nephropathy by protecting podocytes through the SIRT1/HIF-1α pathway[J].Front Endocrinol(Lausanne),2022,13:888611.
  112. 112.
    ZHOU C Y.Study on the protective mechanism of Zhuang medicine compound Xiancao granules on renal podocyte injury induced by high glucose in mice[D].Nanning:Guangxi University of Chinese Medicine,2022.
  113. 113.
    YAN G C.The retrospective analysis of Jiedu Tongluo Baoshen Formula in the treatment of diabetic kidney disease and the mechanism study of podocyte protection[D].Changchun:Changchun University of Chinese Medicine,2023.
  114. 114.
    GU Y,SHEN Y H,DING X,et al.Danggui Buxuetang-containing serum alleviates endoplasmic reticulum stress in diabetic kidney disease to inhibit podocyte apoptosis via PERK/ATF4/CHOP pathway[J].Chin J Exp Tradit Med Form,2024,30(16):10-18.
  115. 115.
    SHEN Q,ZHAO D,WANG L,et al.Protective effect of Huangqi decoction on high glucose-induced podocyte injury and its mechanism[J].Mod J Integr Tradit Chin West Med,2020,29(5):457-462,493.
  116. 116.
    NING H Y,QI T,GAO F,et al.Effects of Modified Shenqi Pills on endoplasmic reticulum stress-induced apoptosis in kidneys of mice with diabetic kidney disease[J].World Chin Med,2025,20(9):1486-1493,1498.
  117. 117.
    ZHANG L,YANG Z,ZHAO Y,et al.Renoprotective effects of Gushen Jiedu capsule on diabetic nephropathy in rats[J].Sci Rep,2020,10(1):2040.
  118. 118.
    GU Y,ZHENG L L,GUO D Z.Danggui Buxuetang inhibits mitochondrial fission and apoptosis of podocytes in rat of diabetic kidney disease via AKAP1/Drp1 signaling pathway[J].Chin J Exp Tradit Med Form,2024,30(15):38-45.
  119. 119.
    ZHANG P,LIU Z,MA G,et al.Huaiqihuang(HQH)protects podocytes from high glucose-induced apoptosis and inflammation response by regulating PI3K/Akt/mTOR pathway[J].Arch Physiol Biochem,2025,131(2):285-292.
  120. 120.
    LIU C L,WANG L L,YANG W,et al.Effects of Yishen Huashi granule on renal injury in diabetic rats via regulation of PI3K/Akt signaling pathway[J].Chin J Gerontol,2021,41(8):1699-1704.
  121. 121.
    ZHANG K J,WANG Y Q,CHU Q G,et al.Influence of Didang Xianxiong Decoction on apoptosis of podocytes in diabetes rats through PI3K/Akt signaling pathway[J].Chin J Exp Tradit Med Form,2024,30(12):62-69.
  122. 122.
    LU Y M.Study on the molecular mechanism of intervention by Gan-songYin on autophagy-apoptosis of renal podocytes and renal tubular epithelial cells in mice induced by high glucose[D].Yinchuan:Ningxia Medical University,2021.
  123. 123.
    WANG W W,LIU Y L,WANG M Z,et al.Inhibition of renal tubular epithelial mesenchymal transition and endoplasmic reticulum stress-induced apoptosis with Shenkang Injection attenuates diabetic tubulopathy[J].Front Pharmacol,2021,12:662706.
  124. 124.
    CAI Y M,WANG S T,ZHOU X,et al.Effect of Shenkang Injection on podocyte apoptosis and GRP78/CHOP signaling pathway in db/db mice with diabetic kidney disease based on endoplasmic reticulum stress[J].Chin J Exp Tradit Med Forme,2025,31(12):81-90.
  125. 125.
    WEI M Y.Study on the mechanism of Keluoxin capsule for diabetic nephropathy based on PERK-ATF4-CHOP signaling pathway[D].Beijing:China Academy of Chinese Medical Sciences,2022.
  126. 126.
    ZHANG H,LYU S Q,PAN B C.Study on the mechanism of Sanhuang Yishen capsule in inhibiting apoptosis of renal tissue cells in DKD rats based on IRE1/GPR78 signaling pathway[J].Tianjin J Tradit Chin Med,2024,41(5):642-648.
  127. 127.
    JING X,ZHENG B I,SIHAI W,et al.Danzhi Jiangtang capsule reduces renal injury in rats with diabetes induced by high fat diet and streptozotocin downregulating toll-like receptor 4-nuclear factor-κB pathway and apoptosis[J].J Tradit Chin Med,2023,43(2):312-321.
  128. 128.
    GUO J M,FU Y T,SUO D W,et al.Study on Acanthopanax senticosus Injection on alleviating renal injury in diabetic kidney disease mice by inhibiting TLR4/NF-κB signaling pathway[J].Tianjin J Tradit Chin Med,2025,42(1):100-107.
  129. 129.
    ZHU B,FANG J,JU Z,et al.Zuogui Wan ameliorates high glucose-induced podocyte apoptosis and improves diabetic nephropathy in db/db mice[J].Front Pharmacol,2022,13:991976.
  130. 130.
    ZHOU L,WANG Y C,GAO R R,et al.Mechanism of Colquhounia Root Tablets in inhibiting podocyte apoptosis of diabetic kidney disease[J].World Chin Med,2025,20(7):1119-1127.

続きを読む

The above content is generated by Large Model Translation. The translated content is for reference only. We do not assume any commercial or legal responsibilty for any consequences arising from the use of our website